Axxcess Wealth Management’s Ginkgo Bioworks DNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,316
| Closed | -$17.6K | – | 902 |
|
|
2024
Q2 | $17.6K | Sell |
1,316
-3,649
| -73% | -$48.8K | ﹤0.01% | 838 |
|
|
2024
Q1 | $230K | Buy |
4,965
+1,295
| +35% | +$60.1K | 0.01% | 758 |
|
|
2023
Q4 | $248K | Sell |
3,670
-350
| -9% | -$23.7K | 0.01% | 711 |
|
|
2023
Q3 | $291K | Buy |
4,020
+1,572
| +64% | +$114K | 0.01% | 605 |
|
|
2023
Q2 | $182K | Buy |
2,448
+505
| +26% | +$37.6K | 0.01% | 558 |
|
|
2023
Q1 | $103K | Buy |
1,943
+632
| +48% | +$33.6K | 0.01% | 613 |
|
|
2022
Q4 | $88.6K | Sell |
1,311
-336
| -20% | -$22.7K | 0.01% | 596 |
|
|
2022
Q3 | $206K | Sell |
1,647
-113
| -6% | -$14.1K | 0.02% | 492 |
|
|
2022
Q2 | $168K | Buy |
1,760
+671
| +62% | +$64.1K | 0.02% | 499 |
|
|
2022
Q1 | $176K | Buy |
+1,089
| New | +$176K | 0.01% | 592 |
|